Crossmark

Fixed-ratio combination of GLP-1 receptor agonist and basal insulin: simplifying type 2 diabetes treatment

Crossref DOI link: https://doi.org/10.1007/s12020-025-04243-6

Published Online: 2025-04-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Longo, Miriam https://orcid.org/0000-0002-6459-5854
Maiorino, Maria Ida https://orcid.org/0000-0003-4659-7546
Giugliano, Dario https://orcid.org/0000-0002-9377-873X
Knop, Filip K. https://orcid.org/0000-0002-2495-5034
Esposito, Katherine https://orcid.org/0000-0002-3652-5154
License Information

Text and Data Mining valid from 2025-04-24

Version of Record valid from 2025-04-24
More Information

Article History

Received: 25 March 2025

Accepted: 16 April 2025

First Online: 24 April 2025

Compliance with ethical standards

:

: The authors declare no competing interests.